Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
179 Results for "
Targeted Therapy
" in MedChemExpress (MCE) Product Catalog:
Products (179)
179 Results for "Targeted Therapy" in MCE Product Catalog:
2
Target:
Forschungsgebiete:
2
Category:
Alkaloids Neurological Disease Datura stramonium L. Other Alkaloids Plants Solanaceae Disease Research Fields Endocrinology
Target:
2
2 Cited Publications
Art. -Nr.: HY-B0459A
CAS. Nr.: 85700-55-6
Synonyms: 6,7-Epoxytropine hydrochloride
Target:
Forschungsgebiete:
Scopine hydrochloride is a metabolite of Scopolamine (HY-N0296) and brain-targeting compound. Scopine hydrochloride significantly increases the brain exposure of Chlorambucil (HY-13593) and enhances its anti-glioma activity. Scopine hydrochloride can be used in targeted therapy research for brain gliomas .
1
Category:
Human Gut Microbiota Metabolites Polysaccharides Microorganisms Other Diseases Endogenous metabolite Disease Research Fields Saccharides
Target:
1
1 Cited Publications
Art. -Nr.: HY-13912G
CAS. Nr.: 686770-61-6
1
Forschungsgebiete:
5-Iodo-cytidine (5-Iodo-D-cytidine) is a purine nucleoside analog that acts as an intermediate in organic synthesis. 5-Iodo-cytidine serves as a chemically modified nucleotide to replace partial cytidine residues in in vitro transcription, enhancing the translation efficiency and stability of chemically modified mRNA. Purine nucleoside analogs exhibit broad anti-tumor activity and target indolent lymphoid malignancies. 5-Iodo-cytidine can be used in mRNA therapy and tumor-related research .
1
1 Cited Publications
Art. -Nr.: HY-P99144A
Target:
Forschungsgebiete:
1
Synonyms: 14-D-Valine-TPL
Target:
Forschungsgebiete:
WBC100 (14-D-Valine-TPL) is a potent, selective, and orally active c-Myc molecule glue degrader. WBC100 is a c-Myc degrader and targets ubiquitin E3 ligase CHIP mediated 26S proteasome pathway. WBC100 is used for c-Myc overexpressing tumors research .
Art. -Nr.: HY-P2213
CAS. Nr.: 109053-09-0
ARS-1323-alkyne is a covalent inhibitor probe that covalently binds to the Switch-II pocket (S-IIP) of the KRAS G12C mutant protein. ARS-1323-alkyne visualizes the covalent modification of KRAS G12C and quantitatively measures the binding efficiency of the inhibitor to the target. ARS-1323-alkyne can be used to validate the target occupancy of KRAS G12C inhibitors and the synergistic mechanism of combination therapy .
Target:
Forschungsgebiete:
PCNA-I1 is a selective small molecule inhibitor targeting proliferating cell nuclear antigen (PCNA) with anticancer activity. PCNA-I1 can stabilize the PCNA trimer structure (Kd=0.14-0.41μM), reduce its binding to chromatin, induce tumor cell cycle arrest, inhibit DNA replication and repair, and enhance the anti-tumor effect of DNA damaging agents. PCNA-I1 can be used in the study of targeted therapy for prostate cancer, lung cancer and other tumors .
Art. -Nr.: HY-W008951
CAS. Nr.: 1429-50-1
Synonyms: EDTMP
Target:
Forschungsgebiete:
CYT296 is a target chromatin de-condensation compound. CYT296 can improve the induction of induced pluripotent stem cell (iPSCs) mediated by defined factors (OSKM) and induce an open chromatin state in Mouse Embryonic Fibroblast (MEFs) to facilitate somatic cell reprogramming. CYT296 can be used for cell replacement therapies and drug screening research .
Art. -Nr.: HY-P990059
CAS. Nr.: 2760250-47-1
Synonyms: INT-016; AZD8205 Antibody
Target:
Forschungsgebiete:
Art. -Nr.: HY-139564
CAS. Nr.: 1908409-18-6
Forschungsgebiete:
DOTA Zoledronate is a next-generation agent for bone targeted radionuclide therapy for diagnosing bone metastases .
Art. -Nr.: HY-P5911
Target:
Forschungsgebiete:
Art. -Nr.: HY-164574
CAS. Nr.: 2565792-45-0
Forschungsgebiete:
BCN-DOTA is a cyclooctyne-linked DOTA chelator. BCN-DOTA integrates BCN and DOTA, enabling conjugation with azide-functionalized groups via the click chemistry properties of BCN, while binding to metal ions through the coordination capacity of DOTA. BCN-DOTA can serve as a radionuclide-drug conjugate (RDC) to target specific biomolecules, cells or tissues after radiolabeling with zirconium-89. BCN-DOTA is applicable to research related to PET imaging and targeted therapy .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
